Aton Ra Partners Edwards Lifesciences Corp Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Aton Ra Partners holds 2,789 shares of EW stock, worth $211,740. This represents 0.42% of its overall portfolio holdings.

Number of Shares

2,789

Previous 3,101 10.06%

Holding current value

$211,740

Previous $214,000 0.93%

% of portfolio

0.42%

Previous 0.45%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$61.71 - $77.76 $19,253 - $24,261	-312 Reduced 10.06%	2,789 $212,000
Q3 2023 Oct 25, 2023	BUY	$69.28 - $93.38 $623 - $840	9 Added 0.29%	3,101 $214,000
Q2 2023 Jul 18, 2023	SELL	$81.41 - $94.33 $48,846 - $56,598	-600 Reduced 16.25%	3,092 $291,000
Q1 2023 May 05, 2023	SELL	$74.26 - $84.51 $38,540 - $43,860	-519 Reduced 12.32%	3,692 $305,000
Q4 2022 Feb 02, 2023	SELL	$68.3 - $87.44 $65,021 - $83,242	-952 Reduced 18.44%	4,211 $314,000
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $70,343 - $91,625	-854 Reduced 14.19%	5,163 $427,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $787,842 - $1.17 Million	-9,108 Reduced 60.22%	6,017 $572,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $777,037 - $978,079	-7,621 Reduced 33.5%	15,125 $1.78 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $838,727 - $1.03 Million	7,885 Added 53.06%	22,746 $2.95 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $230,930 - $275,451	2,244 Added 17.79%	14,861 $1.68 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $69,587 - $86,950	-830 Reduced 6.17%	12,617 $1.31 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $926,693 - $1.07 Million	-11,778 Reduced 46.69%	13,447 $1.13 Million
Q4 2020 Feb 19, 2021	BUY	$71.69 - $91.23 $1.81 Million - $2.3 Million	25,225 New	25,225 $2.3 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account